No Data
No Data
Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase
Unpleasant Surprises Could Be In Store For Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) Shares
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
Baird Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $26
Nurix Therapeutics Showcases Breakthrough BTK Degraders
Nurix Therapeutics, Inc. (NRIX): This Small-Cap Healthcare Stock Is A Good Buy Right Now